Latest News | SPARC Shareholders Approve Appointment of Anilkumar Raghavan as CEO

New Delhi, Sep 30 (PTI) Sun Pharma Advanced Research Company (SPARC) on Thursday said its shareholders have approved the appointment of Anilkumar Raghavan as chief executive officer.

The company's shareholders have approved the "appointment of Anilkumar Raghavan as the manager and whole-time key managerial personnel of the company, designated as chief executive officer (CEO), for a term of 5 years effective from May 25, 2021, up to May 24, 2026," SPARC said in a regulatory filing.

Also Read | Beware! This Kaun Banega Crorepati WhatsApp Lottery Scam Can Make You Lose All Your Money.

On the recommendation of the company's board of directors, the members at the annual general meeting (AGM) have approved an increase in the authorised share capital of the company from the current Rs 37.50 crore divided into 37,50,00,000 equity shares of Re 1 each to Rs 42.50 crore divided into 42,50,00,000 equity shares of Re 1 each, it added.

Shares of Sun Pharma Advanced Research Company on Thursday closed at Rs 295.85 per scrip on the BSE, up 0.39 per cent from its previous close. HRS hrs

Also Read | Rajasthan Shocker: Man Beaten to Death By Two Sons In Barmer District; Accused Arrested.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)